A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Multicenter Study to Evaluate the Efficacy and Safety of Flexibly-Dosed Extended-Release (ER) Paliperidone as Maintenance Treatment After an Acute Manic or Mixed Episode Associated With Bipolar I Disorder.

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Multicenter Study to Evaluate the Efficacy and Safety of Flexibly-Dosed Extended-Release (ER) Paliperidone as Maintenance Treatment After an Acute Manic or Mixed Episode Associated With Bipolar I Disorder.

Completed
Phase of Trial: Phase III

Latest Information Update: 30 Oct 2012

At a glance

  • Drugs Olanzapine; Paliperidone
  • Indications Bipolar I disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Mar 2012 Additional locations (France, Serbia) added as reported by ClinicalTrials.gov.
    • 24 Jun 2010 Actual patient number changed from 732 to 768 as reported by ClinicalTrials.gov.
    • 24 Jun 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top